Clinical Trials Directory

Trials / Completed

CompletedNCT05090683

Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
198 (actual)
Sponsor
University of the Fraser Valley · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Not accepted

Summary

We are investigating the effects of a mind-body based mobile application on the experience of chronic pain. Participants meeting our criteria for chronic pain (confirmed via self-report) will complete an online baseline questionnaire. Eligible participants will be enrolled in the study and randomized into control (usual care, waitlisted) or intervention group (6-week mind-body based mobile application intervention). Randomization will be stratified by pain intensity and gender using computer-generated block randomization to create varying block sizes of 4 and 8. We will run the trial in multiple cohorts in series to obtain desired sample size. All participants will complete online questionnaires at baseline and post-intervention at 6 weeks that measure pain intensity, interference with daily living, pain perceptions, mental health outcomes, and medication use. Participants will also complete weekly questionnaires on weeks 2 to 6 to gauge frequency of application usage (intervention) or other pain treatments (control). Participants in the intervention group will be asked to repeat the follow-up questionnaire at 12-weeks.

Detailed description

See protocol for more details. (submitted at time of registration)

Conditions

Interventions

TypeNameDescription
BEHAVIORALMind-body mobile applicationSelf-directed; Study team will recommend daily use of mobile app for 6 weeks with a minimum of 4 times/week usage of mobile app for 6 weeks. Frequency will be monitored via weekly surveys.

Timeline

Start date
2021-10-15
Primary completion
2022-06-15
Completion
2022-07-15
First posted
2021-10-25
Last updated
2025-01-29
Results posted
2025-01-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05090683. Inclusion in this directory is not an endorsement.